Panoramic Analysis: Current Regulatory Status and Compliance Challenges of Exosome Cosmetics Worldwide

Globally, the regulatory landscape for exosome cosmetics exhibits significant variability. This article systematically reviews the management measures, regulations, and ethical standards concerning exosome cosmetics in various countries/regions, including the United States, the European Union, Japan, South Korea, Taiwan, and mainland China. It explores the context of compliance and prohibitions, as well as their impact on industry development, providing comprehensive global regulatory compliance guidance for cosmetic companies.

Taiwan Updates the List of Ingredients Restricted in Cosmetic Products

On November 6, 2025, Taiwan's Food and Drug Administration (TFDA) released the updated list of restricted cosmetic ingredients. The key revisions are as follows: Deletion of One Ingredient: The use of boric acid in cosmetics is completely banned. Boric acid and its salts, previously listed as restricted ingredients, have been removed from the list of restricted substances. Addition of 34 Ingredients: The total number of restricted ingredients has increased from 186 to 219, with 34 new substances added to the list of restricted cosmetic ingredients. Revision of 74 Entries: A total of 74 entries have been revised in the updated list of restricted cosmetic ingredients.

Taiwan (ROC) Issues Draft Amendment to the "List of Prohibited and Restricted Ingredients in Cosmetic Products (Draft)"

On April 7, 2025, the Separate Customs Territory of Taiwan, Penghu, Kinmen and Matsu issued notification G/TBT/N/TPKM/559, announcing the draft amendment to the "List of Prohibited and Restricted Ingredients in Cosmetic Products (Draft)." The comment period for this draft is 60 days from the date of notification, and the amendment is expected to take effect on July 1, 2026.